Antibe Therapeutics Inc.

(ATE:CA)

By |

Profile

Antibe Therapeutics Inc is a human drug development company. It is engaged in the development of patents and out-licensing of improved compounds of existing drugs. Its product includes ATB-346 a hydrogen sulfide-releasing derivative of naproxen.

Contact Information

Website: www.antibethera.com
Main Phone: +1 905 726-0995
Address: 15 Prince Arthur Avenue
State: ON
City / Town: Toronto
Country: CAN
Postal Code: M5R 1B2

Issuer Information

Exchange: CDX
NAICS: Pharmaceutical P
$ 0.085 $ -0.005 (-5.56%)
Last Price 0.085 Change $ -0.005 Change % -5.56 Tick N/A
Bid 0.085 Bid Size 217,000.00 Ask 0.09 Ask Size 184,000.00
Open 0.09 High 0.09 Low 0.085 Prev Close 0.09
Last Trade Volume 186,555 52 Wk Hi 0.29 52 Wk Low 0.085
Market Cap 9.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 113,098,314.00 EPS (TTM) -0.06 PE Ratio N/A Exchange TSXV
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 0.4 0.4 0.4 0.4
Low Target Price Estimate 0.4 0.4 0.4 0.4
Mean Target Price Estimate 0.4 0.4 0.4 0.4
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 04/11/16 04/11/16 04/11/16 04/11/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1